Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled clinical trial

Journal:

Journal of Hepatology

Published:

2025-07-16

DOI:

10.1016/j.jhep.2025.06.019

Affiliations:

28

Authors:

69

Go to article

Institutions	Authors	Share
CHRU de Besançon, France	6.000000	0.21
Unité Mixte de Recherche RIGHT, France	3.000000	0.11
Centre d'Investigation Clinique de Besançon, France	2.000000	0.07
Centre Hospitalier Intercommunal de Créteil (CHIC), France	1.000000	0.04
Hôpital Pontchaillou, France	1.000000	0.04
AP-HP Beaujon Hospital, France	1.000000	0.04
Hôpital de la Croix-Rousse, HCL, France	1.000000	0.04
Rouen University Hospital-Charles Nicolle (CHU de Rouen), France	1.000000	0.04
Centre Hospitalier Universitaire d'Angers (CHU d'Angers), France	1.000000	0.04
CHU Caen, France	1.000000	0.04
Centre Hospitalier Universitaire de Lille (CHU Lille), France	1.000000	0.04
CHU Amiens-Picardie, France	1.000000	0.04
Chrono-Environment Laboratory, France	1.000000	0.04
Saint-Éloi Hospital, France	1.000000	0.04
Hôpital Trousseau, France	1.000000	0.04
AP-HP Pitié-Salpêtrière Hospital, France	1.000000	0.04
Hôpital Purpan, CHU-Toulouse, France	1.000000	0.04
Robert Debré University Hospital, France	1.000000	0.04
Mediterranean Centre for Molecular Medicine (C3M), France	0.500000	0.02
CHU Nice, France	0.500000	0.02
Hôpitaux Universitaires Paris Seine-Saint-Denis (GHU 93), France	0.500000	0.02
Cordelier Research Center (CRC), France	0.500000	0.02

Interested in Clinical Sciences?